Intangible Assets (Tables)

12 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Components of Intangible Assets

Intangible assets at September 30 consisted of:

	2022						2021
(Millions of dollars)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Amortized intangible assets
Developed technology	$	15,087	$	(5,979)	$	9,108	$	14,399	$	(4,983)	$	9,417
Customer relationships	4,853		(2,170)		2,683		4,653		(1,838)		2,815
Product rights	97		(72)		25		123		(83)		40
Trademarks	408		(155)		253		409		(137)		271
Patents and other	542		(346)		196		523		(339)		184
Amortized intangible assets	$	20,987	$	(8,723)	$	12,264	$	20,106	$	(7,381)	$	12,726
Unamortized intangible assets
Acquired in-process research and development	$	44					$	44
Trademarks	2						2
Unamortized intangible assets	$	46					$	46

Reconciliation of Goodwill by Business Segment

The following is a reconciliation of goodwill by business segment:

(Millions of dollars)	Medical		Life Sciences		Interventional		Total
Goodwill as of September 30, 2020	$	10,028	$	837	$	12,739	$	23,604
Acquisitions (a)	193		—		72		264
Purchase price allocation adjustments	4		—		1		6
Currency translation	15		(1)		(2)		12
Goodwill as of September 30, 2021	$	10,240	$	836	$	12,810	$	23,886
Acquisitions (b)	814		71		188		1,073
Purchase price allocation adjustments	1		—		(2)		(1)
Currency translation	(145)		(20)		(171)		(337)
Goodwill as of September 30, 2022	$	10,909	$	888	$	12,824	$	24,621

(a)Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.

(b)Primarily represents goodwill recognized in the Medical segment upon the Company's acquisition of Parata, which is further discussed in Note 11. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.